booksshare.net -> -> -> .. -> " - " -> 219

- - ..

.., .. - .: , 2002. 182 c.
( ): pharmazeutischewirkstoffe1982.djvu
<< 1 .. 213 214 215 216 217 218 < 219 > 220 221 222 223 224 225 .. 345 >>

Aus Cholesterin:
Ullmann, 3. Auflage, Bd. 8,648.
G. Rosenkranzet al., J. Org. Chem. 21,520 (1956). USP 2 335 616 (Parke Davis; ert. 1943; Prior. 1941).
D: Gero Hormetten® (Hormon)-Komb. Sulfat Gyno Hormetten® (Hormon)-Komb. Sulfat GB: Diandrone (Organon)
I: Astenile® (Recordati)-Na-Sulfat 17-Chetovis® (Vister)-Acetat
Deandros® (Farmochimica)
Dinistenile® В 12 (Recordati)-Komb. Mentalormon® (Sit)
Ormodiamin® (Pharma Farm. Spe.)-Komb. Psicosterone® (Inst. Chem. Italiano)
J: Mylis® (Kanebo)
Prasterononanthat 23983-43-Э
3j8 -hydroxyandrost-5-en-17-one-enanthate
Psychotropicum
Prasterononanthat - Prazepam P 747
о
Л I 1 I* ) ■ « ,. лл, „ [Pyridinj
+ (CfiHi3 C0)20 -
1 ]h j H
Prasteron Onanthsaure-
(s S. 746) anhydrid
DOTH, 465(1975).
Belg-P 721 825 (Schering AO; Anm. 4.10.1968; D-Prior. 4.10.1967).
SA-P 686 112 (Schering AG; Anm. 20.9.1968; D-Prior. 4.10.1967).
GB-P 1 246 639 (Schering AG; Laufzeit ab 30.9.1968; D-Prior. 4.10.1967).
Weiteres Verfahren:
DOS 2 534911 (Schering AG; Anm. 1.8.1975).
Anwendung gegen Psoriasis:
DOS 2 147 309 (Schering AG; Anm. 17.9.1971).
D: Gynodian® Depot (Schenng)-Komb. I: Gynodian® Depot (Schering)-Komb.
F: Gynodian® Depot (Schering)-Komb.
CgHi3—CO—O'
Prasterononanthat
Prazepam 2955-38-6 Tranquilizer
7-chloro-l-(cyclopropylmethyl)-l,3-dihydro-5-phenyl-2//-l,4-benzodiazepin-2-one
у*
+ » алДс^о
6 ° 6
Litfuum-
alanat
NH
CH-0H
2-Amino-5-chtor- Cyclopropan-benzophenon carbonsaurechlorid
CH2-<]
NH
Phthalimidoaeetylchlorid
5-Chtor-2-(cyctopropyl-
methylamtnoj-benzophenon
6
MangarllV).
oxid
У NaH
2 Br—CH2-<]
1 Natnumhydrid
2 Cyclopropyl-methyl bromid
7-Chtor-2-oxo-5-phenyl-
2,3-dihydro-1tf-Vi-
benzodiazepin *
Prazepam
748 P Prazepam - Praziquantel - Prazosin
* vgl. Diazepam-Synthese, S. 288
DOT2, 119(1966);9,237 (1973); 10, 181 (1974).
a DAS 1229 098 (Warner-Lambert; Anm. 24.2.1964; USA-Prior. 1.3.1963).
VSP3 192199 (F. H. McMillan u. J, Pattison; ert. 29.6.1965; Anm. 1.3.1963). b USP 3 192 200 (H. M. Wuest; ert. 29.6.1965; Prior. 5.3.1963).
Weiteres Verfahren:
S. Inaba et al., Chem. Pharm. Bull. 17,1263 (1969).
D: Demetrin® (Godecke) USA: Verstran® (Warner-Chilcott)
F: Lysanxia® (Substantia)
Praziquantel
55268-74-1
Anthelminticum
СНг-
NH
Об
1-Aminonnethyl-
I^^A-tetrahydro-
isochinolin
1 Cl —CHj-COOH
2 {^>-coa
1. Chloressigsaure
2. Cyclohexancar-bonsaurecrtlorid
c-0
I
H2C CH2 NH COOH
w
1-(/V-Carboxymethyl-A/-cyclohexylcarbonyl-aminomethyl)-1,2,3^-tetrahydroisochinolin
Praziquantel
Isochinolm
0-ci
Cyclohexancar-
bonsaurechforid
H CN
H2 /Raney-Ni
CO
I
HN.
CH2
06"
Chlocacstyt-
chtorid
0
СНг II
0б“
СН2С1
Praziquantel
DOS 2 457 971 (E. Merck Patent GmbH; Anm. 7.12.1974). DOS 2 362 539 (E. Merck Patent GmbH; Anm. 17.12.1973). DOS 2 504 250 (E. Merck Patent GmbH; Anm. 1.2.1975).
D: Biltricide® (Bayer)
Cesol® (Merck)
Prazosin
19216-56-9
19237-84-4
Hydrochlorid
Anthypertonicum
l-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-piperazine
Prazosin - Prednimustin P 749
H3COv^\^NH2
h3co'^'tooh
2-Amino-^5-
dimethoxy-
benzoesaure
Natrium-
cyanat
OH
2Ji-Oihydroxy-6J7-d imethoxychinazoi in
«зИ^ЛчЛ»
НзСо^Д^а
2,4-ОкЫог-6,7-
dimethoxychinazotin
nh2
H3CO''^-^N>^Ct
4'Amino-2-chlor-
6,7-dimethoxychinazolin
M2-Furoyl)-piperazm
DOTH, 64,67,80(1975).
USP 3 511 836 (Pfizer; ert. 12.5.1970; Anm. 13.12.1967; Prior. 6.8.1965, 7.6.1966). USP 3635 979 (Pfizer; ert. 18.1.1972; Prior. 6.8.1965, 7.6.1966,13.12.1967).
USP 3 663 706 (Pfizer; ert. 16.5.1972; Prior. 6.8.1965, 13.12.1967, 12.5.1970).
DAS 1 620 138 (Pfizer; Anm. 2.7.1966; USA-Prior. 6.7.1965, 7.6.1966). Alternativ-Synthese:
USP 3 935 213 (Pfizer; ert. 27.1.1976; Prior. 5.12.1973).
DOS 2 457 911 (Pfizer; Anm. 4.12.1974; USA-Prior. 5.12.1973).
DOS 2 731 737 (Pfizer; Anm. 11.7.1977; USA-Prior. 6.8.1976).
USP4062 844 (Pfizer; ert. 13.12.1977; Anm. 20.9.1976).
USP 4138 561 (Bristol-Myers; ert. 6.2.1979; Prior. 30.9.1977).
Belg-P 861 821 (Fermion; Anm. 14.12.1977; SF-Prior. 15.12.1976).
Belg-P 861 822 (Fermion; Anm. 14.12.1977; SF-Prior. 15.12.1976). a-Form:
USP 4092 315 (Pfizer; ert. 30.5.1978; Anm. 1.3.1976).
DAS 2 708 192 (Pfizer; Anm. 25.2.1977; USA-Prior. 1.3.1976).
D: Minipress® (Pfizer) Г: Minipress® (Pfizer)
G8: Minipress®(Pfizer) USA: Minipress®(Pfizer)
Sinetens® (Carlo Erba)
Prednimustin 29069-24-7 Cytostaticum
ll/3,17,21-trihydroxypregna-l,4-diene-3,20-dione 21-[4-[/>[bis-(2-chloroethyl)amino]phenyl]butyrate]
H0-CH2

Prednisolon 4-{4-[8is-(2-chlorethyl]-amino] - phenyl)-
(s, S. 750) buttersaureanhydnd
750 P Prednimustin - Prednisolamat - Prednisolon
Prednimustin
DOF1, 138 (1976); 5,158 (1980).
DOT 16, 82 (1980).
DOS 2 001 305 (A В Leo; Anm. 13.1.1970; GB-Pnor. 23.1.1969). F: Stereocyte® (Roger Bellon)
PredniSOlamat 5626-34-6 Glucocorticoid
17140-01-1 Hydrochlorid
11/3.17,21-trihydroxypregna-l,4-diene-3,20-dione 21-<V, Л'-diethylglycme ester
<< 1 .. 213 214 215 216 217 218 < 219 > 220 221 222 223 224 225 .. 345 >>

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

, ?
2009 BooksShare.
.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed